Drug Shortage Report for NAT-LEVETIRACETAM

Last updated on 2019-04-17 History
Report ID 64878
Drug Identification Number 02440210
Brand name NAT-LEVETIRACETAM
Common or Proper name LEVETIRACETAM Tablets
Company Name NATCO PHARMA (CANADA) INC
Active Ingredient(s) LEVETIRACETAM
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 120
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2018-09-26
Actual start date 2018-09-26
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-04-17
Company comments
Health Canada comments
Contact Address 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5N 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2019-04-17 French Compare
v21 2019-04-17 English Compare
v20 2019-02-15 French Compare
v19 2019-02-15 English Compare
v18 2019-02-15 French Compare
v17 2019-02-15 English Compare
v16 2019-02-15 English Compare
v15 2019-02-04 French Compare
v14 2019-02-04 English Compare
v13 2019-02-04 French Compare
v12 2019-02-04 English Compare
v11 2019-01-11 French Compare
v10 2019-01-11 English Compare
v9 2018-12-11 French Compare
v8 2018-12-11 English Compare
v7 2018-12-11 French Compare
v6 2018-12-11 English Compare
v5 2018-10-31 French Compare
v4 2018-10-31 English Compare
v3 2018-10-19 French Compare

Showing 1 to 20 of 22